The Covid epidemic continues to decline, with an average of 24,000 new cases detected daily, or 25% less than last week. The Higher Health Authority (HAS), however, is taking the lead, announcing on Tuesday that it expects the epidemic to resume at the beginning of the school year. «We can talk about vaccinations again, because everything happens as if we finished Covid, but the virus is still circulating,։ we can expect an increase in infection in the fall.“- commented Professor Yves Busson, epidemiologist նախագահ Chairman of the Covid Group of the National Academy of Medicine.
HAS has developed three scenarios: optimistic, intermediate and pessimistic, to imagine how it might turn out for the French. “So far, the intermediate version has been chosen.”transmission peaks that lead to periodic flares“With a virus that”continues to developև immunity, which «decreases over time, but remains heavy enough against the deaths of the majority of the population«.
Forgotten children
Given the accumulated knowledge, in particular about the evolution of this vaccine’s immunity, HAS advises to expect a recall campaign in the fall. This is likely to be a priority for caregivers’s population at high risk for complications, ie people over the age of 65, immunocompromised people, and those around them, as well as those with a pathology that increases the risk of serious Covid infections. :
For those who have followed all the recommended tips, then this will be the 4th dose. But many of these vulnerable people have not yet been vaccinated or given a full regimen. For example, only 76% of people over 80 received the first booster dose, and in many French departments less than 70% of nursing home residents received two doses, according to the Covidtracker website. For Professor Yves Busson, vaccinating children is a major omission from these HAC recommendations.This is open because on the one hand there are serious dogs in the youngest (169 patients aged 0 to 9 are currently hospitalized for Covid, editor’s note), and on the other hand we now know that children are the point of entry. Covid virus in families with regard to influenza. However, studies have shown very high vaccine tolerance and excellent efficacy in young people. Therefore, there is no health reason for not resuming this vaccination.»
The decline of new vaccines against Sars-CoV-2 could expand the arsenal. Several laboratories are working on so-called bivalent RNA vaccines targeting two strains of the virus that could improve their effectiveness. HAS will evaluate these new products ստակ clarify their place in France’s vaccine strategy once they are approved.
Source: Le Figaro
